John D. Lewis
FounderExecutive Officer, Director at Oncosenx · Executive at Oisin Biotechnologies · Founder, Board Chair & CEO at NanoStics
Edmonton, Alberta, Canada
FoundedNanoStics
Find your path to John
1,006 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
About
John D. Lewis holds the Bird Dogs Chair in Translational Oncology at the University of Alberta. His research focuses on cancer metastasis, using advanced live imaging techniques, along with the application of nanotechnology and imaging to chronic diseases including aging and cancer. His research group works to translate new diagnostics and treatments into clinical use.
Executive Officer, Director at Oncosenx
Intro paths
In turn, John can intro founders to Oncosenx's investors below.
Oncosenx's investors · 2
Co-founders at Oncosenx

Executive at Oisin Biotechnologies
Co-founders at Oisin Biotechnologies

Founder, Board Chair & CEO at NanoStics
Intro paths
In turn, John can intro founders to NanoStics's investors below.
NanoStics's investors · 2
Co-founders at NanoStics
Experience
- University of AlbertaBird Dogs Chair in Translational Oncologycurrent2022 — presentEdmonton, Alberta, Canada
- University of AlbertaProfessorcurrent2019 — presentGreater Edmonton Metropolitan Area
- University of AlbertaFrank and Carla Sojonky Chair in Prostate Cancer Research2012 — 2022Greater Edmonton Metropolitan Area
- University of AlbertaAssociate Professor2012 — 2018Edmonton, Canada Area
- Entos PharmaceuticalsFounder, CEOcurrent2016 — presentEdmonton, AB
- Aegis Life, Inc.Founder, CEOcurrent2020 — presentSan Diego, California, United States
- OncoSenXFounder, CSOcurrent2018 — presentSeattle, Washington
- Nanostics IncFounder, CEOcurrent2017 — presentEdmonton, AB
- Oisin BiotechnologiesCSOcurrent2016 — presentSeattle
- Alberta Prostate Cancer Research InitiativeFounding Chair2012 — 2022Alberta, Canada
- Innovascreen IncCEO2005 — 2019
- University of Western OntarioAssistant Professor2006 — 2011
- London Health Sciences CentreRobert Hardie Chair in Translational Prostate Cancer Research2006 — 2011
Skills & more
From John's professional profile.
Frequently asked questions
- Who is John D. Lewis?
- John D. Lewis holds the Bird Dogs Chair in Translational Oncology at the University of Alberta. His research focuses on cancer metastasis, using advanced live imaging techniques, along with the application of nanotechnology and imaging to chronic diseases including aging and cancer. His research group works to translate new diagnostics and treatments into clinical use.
- Where does John D. Lewis work?
- John D. Lewis is Founder, Board Chair & CEO of NanoStics and Executive at Oisin Biotechnologies.
- What companies did John D. Lewis found?
- John D. Lewis founded NanoStics.
- Where did John D. Lewis go to school?
- John D. Lewis studied at Scripps Research (PDF, Nanotechnology); University of Victoria (Ph.D., Biochemistry); Western University (BSc HONS, Genetics).
Founder mafias
University of Victoria mafia59
Also came through, then founded or led a company.
Scripps Research mafia17
Also came through, then founded or led a company.
Oncosenx mafia3
Also came through, then founded or led a company.
Oisin Biotechnologies mafia2
Also came through, then founded or led a company.
Same school
Also attended Scripps Research26
+ 20 more
Also attended University of Victoria134
+ 128 more
Also attended Western University403
+ 397 more






































